LT2000081A - Core tablet for controlled release of gliclazide after oral administration
- Google Patents
Core tablet for controlled release of gliclazide after oral administration
Info
Publication number
LT2000081A
LT2000081ALT2000081ALT2000081ALT2000081ALT 2000081 ALT2000081 ALT 2000081ALT 2000081 ALT2000081 ALT 2000081ALT 2000081 ALT2000081 ALT 2000081ALT 2000081 ALT2000081 ALT 2000081A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires ServierfiledCriticalLes Laboratoires Servier
Priority to LT2000081ApriorityCriticalpatent/LT4932B/en
Publication of LT2000081ApublicationCriticalpatent/LT2000081A/en
Publication of LT4932BpublicationCriticalpatent/LT4932B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The present invention relates to core tablet for controlled release of gliclazide providing continuous and monotonous release of active substance which is insensitive for pH change values in solution media after oral administration.
LT2000081A2000-08-292000-08-29Core tablet for controlled release of gliclazide after oral administration
LT4932B
(en)
Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives.